Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/03/2025 ,inter alia, to consider and approve 1. Increase in Authorised Capital 2. Issue of shares on Preferential Allotment 3. Any other matter with the permission of chair